Delivery Order SPE2DB20D3103-SPE2DB24FL8S5
- Not listed
- This federal contract award is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The contract, valued at $1,473.82, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a delivery date of June 12, 2023 and is a firm-fixed-price delivery order. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award is for the delivery of the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The award, valued at $1,804.52, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 17, 2024. Amerisourcebergen Drug...
- This federal contract award, valued at $2,194.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of May 7, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a...
- The federal contract award is for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The delivery order has a ceiling value of $1,555.60 and a period of performance through May 9, 2025. This contract is not set-aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, the Corporate Office division of the larger Amerisourcebergen Corporation, which is a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $3,190.48 and has an ultimate...
- This federal contract award is for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract has a ceiling value of $6,502.28 and is a Firm Fixed Price Delivery Order that runs through April 30, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to the Department of Defense (DoD) and Department...
- This federal contract award is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $25,058.94 fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 3, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,225.89 and a completion date of March 2, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award is for the delivery of the prescription medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $12,166.79 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of the major pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $9,043.90 and an ultimate completion date of February 28, 2024. It is a firm fixed-price delivery order contract, with no set-aside...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL8S5Delivery Order
This federal contract award is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA). The contract, valued at $3,291.24, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is a delivery order and is priced on a firm fixed-price basis. The contract has an ultimate completion date of December 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued at up to $750,000. These IDCs enable Amerisourcebergen to efficiently deliver a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of the military, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 12/11/23 |